TeMpOH-3
- Conditions
- Prophylactic catheters, balloon catheters, embolisation, embolization, abnormal placentation, abnormally invasive placenta, accreta, increta, percreta.Profylactische katheters, ballonkatheters, embolisatie, abnormale placentatie
- Registration Number
- NL-OMON28238
- Lead Sponsor
- Sanquin, LUMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 750
Inclusion Criteria
The study is a cohort study, carried out in patients at high risk of abnormally invasive placenta who underwent an elective caesarean delivery between January 2008 and January 2013 in the Netherlands.
Exclusion Criteria
Women who had an emergency caesarean delivery.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major obstetric haemorrhage = Obstetric haemorrhage requiring at least four units of red blood cells < 24 hours after delivery
- Secondary Outcome Measures
Name Time Method - The total amounts of used blood products in patients: the number of transfused units of RBCs, plasma (and platelets)<br>- (Severe) maternal morbidity, defined as peripartum hysterectomy or need for other interventions, ICU admission and length of hospitalization.<br>- Complications related to the radiological interventions, and complications related to surgical procedures.<br>- Maternal mortality.